See more : Wihlborgs Fastigheter AB (publ) (WIHLY) Income Statement Analysis – Financial Results
Complete financial analysis of Invictus MD Strategies Corp. (IVITF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Invictus MD Strategies Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Lennar Corporation (0JU0.L) Income Statement Analysis – Financial Results
- Holley Inc. WT (HLLY-WT) Income Statement Analysis – Financial Results
- Analog Devices, Inc. (0HFN.L) Income Statement Analysis – Financial Results
- BCTG Acquisition Corp. (BCTG) Income Statement Analysis – Financial Results
- Korea Flange Co., Ltd (010100.KS) Income Statement Analysis – Financial Results
Invictus MD Strategies Corp. (IVITF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.invictus-md.com
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
| Metric | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|
| Revenue | 3.57M | 1.93M | 1.96M | 2.63M | 0.00 | 0.00 |
| Cost of Revenue | 6.47M | 3.16M | 1.20M | 1.78M | 0.00 | 0.00 |
| Gross Profit | -2.89M | -1.23M | 754.33K | 849.68K | 0.00 | 0.00 |
| Gross Profit Ratio | -80.99% | -63.85% | 38.58% | 32.26% | 0.00% | 0.00% |
| Research & Development | 0.00 | 9.36K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 14.24M | 12.70M | 5.73M | 1.87M | 274.99K | 0.00 |
| Selling & Marketing | 14.45M | 2.75M | 597.91K | 299.69K | 0.00 | 0.00 |
| SG&A | 21.93M | 13.40M | 4.85M | 1.54M | 274.99K | 0.00 |
| Other Expenses | 0.00 | 0.00 | -45.16K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.93M | 13.41M | 4.85M | 1.54M | 274.99K | 0.00 |
| Cost & Expenses | 28.39M | 16.56M | 6.05M | 3.33M | 274.99K | 0.00 |
| Interest Income | 410.61K | 144.15K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 242.47K | 0.00 | 81.30K | 18.06K | 0.00 | 0.00 |
| Depreciation & Amortization | 2.82M | 1.51M | 57.42K | 6.87K | 0.00 | 0.00 |
| EBITDA | -33.41M | -18.77M | -5.27M | -708.24K | -274.99K | 0.00 |
| EBITDA Ratio | -935.00% | -680.92% | -206.67% | -26.13% | 0.00% | 0.00% |
| Operating Income | -24.82M | -14.64M | -4.10M | -695.13K | -274.99K | 0.00 |
| Operating Income Ratio | -694.62% | -759.41% | -209.61% | -26.39% | 0.00% | 0.00% |
| Total Other Income/Expenses | -3.01M | -1.58M | -867.18K | 1.05M | -432.91K | 0.00 |
| Income Before Tax | -27.84M | -16.33M | -4.76M | 76.52K | -707.90K | 0.00 |
| Income Before Tax Ratio | -778.98% | -847.22% | -243.63% | 2.91% | 0.00% | 0.00% |
| Income Tax Expense | -1.27M | -682.94K | -371.40K | 149.08K | 0.00 | 0.00 |
| Net Income | -27.19M | -16.12M | -4.33M | -72.56K | -707.90K | 0.00 |
| Net Income Ratio | -761.00% | -836.48% | -221.23% | -2.76% | 0.00% | 0.00% |
| EPS | -0.35 | -0.24 | -0.41 | -0.18 | -0.83 | -0.01 |
| EPS Diluted | -0.35 | -0.24 | -0.41 | -0.18 | -0.83 | -0.01 |
| Weighted Avg Shares Out | 101.59M | 68.32M | 10.51M | 393.47K | 850.31K | 284.54K |
| Weighted Avg Shares Out (Dil) | 101.59M | 68.32M | 10.51M | 393.47K | 850.31K | 284.54K |
Source: https://incomestatements.info
Category: Stock Reports